![Andrei Shustov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrei Shustov is a former Senior Medical Director-Late Stage Clinical at Seagen Inc. and a former Senior Vice President-Medical at Cellectar Biosciences, Inc. He holds a doctorate degree from S.
I.
Georgievsky's Medical Academy, which he received in 1987.
| Bedrijven | Functie | Einde |
|---|---|---|
| SEAGEN INC. | Corporate Officer/Principal | - |
| CELLECTAR BIOSCIENCES, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
| Bedrijven in privébezit | 3 |
|---|---|
Seagen, Inc.
 Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
Cellectar Biosciences, Inc.
 Cellectar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer | Health Technology |
S. I. Georgievsky's Medical Academy
 S. I. Georgievsky's Medical Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
